Analyst consensus rating
Lifecore Biomedical Analyst Rating: Hold
Direct answer
Lifecore Biomedical's consensus rating is Hold.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $6.28.
Forecast evidence checked November 14, 2026.
Get free Lifecore Biomedical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.42
- Average price target
- $6.28
- High price target
- $6.28
- Low price target
- $6.28
- Low target gap
- -2.2%
- Target upside
- -2.2%
- High target gap
- -2.2%
- Target range width
- 0%
- Consensus rating
- Hold
- Analysts
- 2
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Lifecore Biomedical?
Lifecore Biomedical has a verified Hold consensus. The same dataset has an average price target of $6.28.
How far are Lifecore Biomedical's low and high targets from the recorded price?
The low target implies -2.2%, while the high target implies -2.2%.
How many analysts are included in Lifecore Biomedical's consensus?
The verified consensus includes 2 analysts.
How is Lifecore Biomedical's target upside or downside calculated?
The average target of $6.28 is divided by the recorded price of $6.42, then one is subtracted to produce -2.2%. This does not guarantee a future return.
When was Lifecore Biomedical's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.